Penguin On Site | Weiming Penguin Co-founder and President Tian Ying Attends Kickoff Meeting, Joining Wanze Pharmaceutical on a New Journey in AI-Powered Data Intelligence
Article images may contain Chinese text.
“Intelligence Stirs the Waves of Data—Celebrating the Launch of the Weiming Penguin–Wanze Data Project”
Weiming Penguin and Wanze join on a cloudbound quest, breaking through barriers with data as their aim.
Precise plans and a strong team open the way to success; two leaders' words ring out in the summer air.

I. Weiming Penguin and Wanze Join on a Cloudbound Quest
As the wave of digital transformation sweeps through the pharmaceutical industry, Weiming Penguin embarks on another innovative journey! On July 4, 2025, Weiming Penguin and Wanze Pharmaceutical jointly held the “Pharmaceutical Distribution Data Collection & Intelligent Data Cleansing Project Kickoff Meeting,” officially launching an AI-based system project for pharmaceutical distribution data collection and intelligent data cleansing. Together, they will explore a new future for pharmaceutical data intelligence.

II. Breaking Through Barriers with Data as the Aim
The project launch marks an important step in Weiming Penguin's continued work in pharmaceutical data. For years, issues such as the low efficiency and high error rates of manual data cleansing have severely limited pharmaceutical companies' ability to obtain accurate, timely sales operations data. Weiming Penguin's AI solution is precisely the tool needed to address Wanze Pharmaceutical's data challenges.
III. Precise Plans and a Strong Team Open the Way to Success
Weiming Penguin has laid out a clear, well-defined project plan. The two parties have coordinated their respective roles and milestones in an orderly manner, putting their individual action-plan schedules into practice with precision. Each stage is closely connected to ensure steady project progress.

The project execution team brings substantial expertise. Weiming Penguin has assigned a team of senior experts to take responsibility for solutions, project execution, product management, and overall coordination. It has also established a communication framework encompassing daily internal communication, weekly meetings, quarterly review meetings, and a project wrap-up meeting to keep information flowing efficiently and collaboration running smoothly.
IV. Two Leaders' Words Ring Out in the Summer Air
The kickoff meeting was attended by Chen Lan, director and general manager of Wanze Co., Ltd. and general manager of Wanze Group's pharmaceutical division, along with leaders and colleagues from Shuangqi Pharmaceutical's marketing, commercial operations, information, effectiveness, and other relevant departments. Weiming Penguin Co-founder and President Tian Ying, solution experts, and the heads of its commercial, technology, project, and operations departments participated on site or online.
Both parties place a high priority on the project's success. For potential work involving agile commercial interactions and efficient data cleansing, Weiming Penguin has developed AI-based approaches and will flexibly deploy management tools to safeguard execution speed and implementation quality. Using AI can substantially improve efficiency, processing large volumes of data efficiently in accordance with standards and providing strong support for business decisions.

Leaders on both sides expressed high expectations. In her remarks at the meeting, Weiming Penguin Co-founder and President Tian Ying said she hoped the project would mark a positive beginning for collaboration between the two companies. Drawing on Weiming Penguin's DIG (AI) series of solutions, the company aims to provide AI technology and industry experience to support Wanze Pharmaceutical's awareness of business digitalization and efficient collaboration. Chen Lan, director and general manager of Wanze Co., Ltd., emphasized that the project is both a key component of Wanze's digital transformation and a new infrastructure initiative. She called on the commercial operations department to coordinate with all departments, work backward from deadlines, and incorporate the work into performance assessments, providing more accurate, efficient data support for business decisions and laying a solid digital foundation for Wanze's efficient, precise development in the future.
*About Wanze Pharmaceutical

Wanze Industrial Co., Ltd. (stock code: 000534), known as Wanze Co., Ltd., is listed on the Main Board of the Shenzhen Stock Exchange. Its pharmaceutical business, Wanze Pharmaceutical, has focused on microecological pharmaceuticals for 30 years and has developed a complete industry chain integrating research and development, production, and sales. It is a member of the International Scientific Association for Probiotics and Prebiotics (ISAPP). It is also currently China's largest producer in this field and the only national high-tech enterprise producing microecological preparations that focuses exclusively on the digestive and gynecological microecosystems. Its official website is www.wedge.com.cn. (Information is sourced from the internet. Please refer to the company's official publications and actual circumstances for specific details.)

With the launch of this project, Weiming Penguin's DIG digital foundation will support Wanze Pharmaceutical's digital innovation and help safeguard its rapid growth. Starting here, the two parties will work together toward flourishing progress and shared achievements. This is a new starting point for cooperation between Weiming Penguin and Wanze Pharmaceutical, as well as an exemplary application of AI technology in pharmaceutical data. Looking ahead, Weiming Penguin will continue to harness AI and deepen its work in pharmaceutical data intelligence, joining more partners to bring strong momentum to industry development and chart a new blueprint for pharmaceutical digital transformation!
